| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Dec 3, 2025 | CORCEPT THERAPEUTICS INC | CFO | Sell | 77.5 | +238 | 1.66% | ✗ | $9.4K |
| Sep 2, 2025 | Sep 4, 2025 | CORCEPT THERAPEUTICS INC | CFO | Sell | 78.8 | +256 | 1.82% | ✗ | $10.3K |
| Jun 2, 2025 | Jun 4, 2025 | CORCEPT THERAPEUTICS INC | CFO | Sell | 86.3 | +1,031 | 7.91% | ✗ | $37.2K |
| Mar 3, 2025 | Mar 4, 2025 | CORCEPT THERAPEUTICS INC | CFO | Sell | 78.8 | +236 | 1.84% | ✗ | $13.8K |
| Dec 2, 2024 | Dec 4, 2024 | CORCEPT THERAPEUTICS INC | CFO | Sell | 78.8 | +280 | 2.24% | ✗ | $10.5K |
| Sep 3, 2024 | Sep 5, 2024 | CORCEPT THERAPEUTICS INC | CFO | Sell | 85.0 | +657 | 5.54% | ✗ | $5K |
| Jun 3, 2024 | Jun 5, 2024 | CORCEPT THERAPEUTICS INC | CFO | Sell | 91.3 | +2,325 | 24.38% | ✗ | $17.2K |
| Mar 1, 2024 | Mar 5, 2024 | CORCEPT THERAPEUTICS INC | CFO | Sell | 86.3 | +591 | 6.61% | ✗ | $12.4K |
| Nov 24, 2018 | Dec 13, 2018 | IRIDEX CORP | CFO | Sell | 47.5 | -6,013 | -6.85% | ✗ | $738 |